Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Gsk Plc (GSK.LN)

Gsk Plc (GSK.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 74,000,448
  • Shares Outstanding, K 4,037,622
  • Annual Sales, $ 31,376 M
  • Annual Income, $ 2,575 M
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta N/A
  • Price/Sales 2.36
  • Price/Cash Flow 9.73
  • Price/Book 4.58
  • Price/Earnings ttm 13.78
  • Earnings Per Share ttm 1.33
  • Most Recent Earnings $0.49 on 10/29/25
  • Next Earnings Date N/A
  • Annual Dividend & Yield 0.63 (3.49%)
  • Most Recent Dividend 0.160 on 11/13/25
  • Sector N/A
  • INDUSTRY GROUPING N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
1,753.000 +2.97%
on 11/21/25
1,853.500 -2.62%
on 12/04/25
+17.000 (+0.95%)
since 11/05/25
3-Month
1,445.000 +24.91%
on 09/08/25
1,853.500 -2.62%
on 12/04/25
+329.000 (+22.29%)
since 09/05/25
52-Week
1,242.500 +45.27%
on 04/09/25
1,853.500 -2.62%
on 12/04/25
+463.500 (+34.55%)
since 12/05/24
Free Barchart Webinars! Live educational sessions using site features to explore today's markets.

Most Recent Stories

More News
Blenrep approved by US FDA for use in treatment of relapsed/refractory multiple myeloma Business Wire - Thu Oct 23, 7:11PM CDT

Significant unmet need for patients requires new and novel treatments 1 DREAMM-7 showed a 51% reduction in the risk of death and tripled median progression-free...

GSK.LN : 1,805.000 (-1.15%)
GSK : 48.41 (-0.33%)
New Local Data in GSK and IQVIA's Vaccine Track Supports Smarter Public Health Action at the Community Level Business Wire - Wed Oct 1, 9:00AM CDT

New analysis of metro-area data reveals wide variation in adult vaccination trends across the US and points to opportunities for local action Originally launched in 2022, Vaccine Track...

GSK.LN : 1,805.000 (-1.15%)
GSK : 48.41 (-0.33%)
Trader 2 at NYSE by Orhan Akkurt via Shutterstock
Stocks Set to Open Higher as Bond Yields Fall, Trump’s Shutdown Talks in Focus Barchart - Mon Sep 29, 5:11AM CDT

December S&P 500 E-Mini futures (ESZ25) are up +0.48%, and December Nasdaq 100 E-Mini futures (NQZ25) are up +0.63% this morning, pointing to a higher open on Wall Street as Treasury yields moved lower,...

PCAR : 110.33 (+1.69%)
APP : 691.94 (+1.19%)
MRUS : 96.14 (-0.08%)
CAG : 17.05 (+0.59%)
NKE : 65.86 (+0.26%)
NQZ25 : 25,732.00s (+0.43%)
CCL : 25.87 (+0.19%)
GSK.LN : 1,805.000 (-1.15%)
CRON : 2.49 (unch)
COST : 894.68 (-0.13%)
GFS : 38.95 (+3.65%)
PAYX : 112.06 (+0.26%)
GSK sponsors 2025 National Senior Games as part of Sideline RSV campaign to raise awareness of RSV in older adults Business Wire - Thu Jul 24, 8:00AM CDT

GSK and the National Senior Games team up to spotlight RSV risk, prevention, and the power of proactive health conversations National TV special “Redefining...

GSK.LN : 1,805.000 (-1.15%)
GSK : 48.41 (-0.33%)
US FDA Approves GSK’s SHINGRIX in a Prefilled Syringe Presentation Business Wire WWW - Thu Jul 17, 6:00AM CDT

Prefilled syringe presentation offers a convenient administration option to healthcare professionals An estimated one million people develop shingles...

AGEN : 3.93 (-3.20%)
GSK.LN : 1,805.000 (-1.15%)
GSK : 48.41 (-0.33%)
Spero Therapeutics and GSK Announce PIVOT-PO Phase 3 Study for Tebipenem HBr Stopped Early for Efficacy Following Review by Independent Data Monitoring Committee GlobeNewswire - Wed May 28, 6:00AM CDT

SPRO : 2.26 (-0.88%)
GSK.LN : 1,805.000 (-1.15%)
GSK : 48.41 (-0.33%)
UNITED HEALTHCARE-CEO
UnitedHealth Group CEO steps down as company lowers, then withdraws financial outlook for 2025 Associated Press - Tue May 13, 11:56AM CDT

UnitedHealth Group CEO Andrew Witty is stepping down from his post for personal reasons and the health care giant says it’s suspending its full-year forecast due to higher-than-expected medical costs...

HUM : 257.85 (+1.91%)
$SPX : 6,870.40 (+0.19%)
$DOWI : 47,954.99 (+0.22%)
$IUXX : 25,692.05 (+0.43%)
GSK.LN : 1,805.000 (-1.15%)
UNH : 330.91 (-0.77%)
Financial Markets Wall Street Caterpillar
Tariff turmoil prompts cloudy forecasts from companies for the year ahead Associated Press - Wed Apr 30, 12:16PM CDT

Uncertainty continues to hang over the latest round of financial results and forecasts for companies both big and small as they try to navigate a global trade system severely shaken by a stark shift in...

SYY : 73.10 (-0.46%)
NWL : 3.72 (+0.81%)
FSLR : 257.61 (+0.13%)
SWK : 72.47 (+0.36%)
$SPX : 6,870.40 (+0.19%)
BARC.LN : 434.400 (-1.09%)
$DOWI : 47,954.99 (+0.22%)
GSK.LN : 1,805.000 (-1.15%)
$IUXX : 25,692.05 (+0.43%)
Alector Announces Completion of Enrollment in the PROGRESS-AD Phase 2 Clinical Trial of AL101/GSK4527226 in Individuals with Early Alzheimer’s Disease GlobeNewswire - Thu Apr 17, 7:00AM CDT

ALEC : 1.2200 (+0.83%)
GSK.LN : 1,805.000 (-1.15%)
GSK : 48.41 (-0.33%)
Nasdaq Times Square by Lucky Photographer via iStock
Nasdaq Futures Plunge as Alphabet and AMD Earnings Disappoint, U.S. ADP Jobs Report in Focus Barchart - Wed Feb 5, 4:46AM CST

March Nasdaq 100 E-Mini futures (NQH25) are trending down -0.91% this morning as disappointing results from Alphabet and Advanced Micro Devices weighed on sentiment.

GOOGL : 321.27 (+1.15%)
MAT : 21.15 (+0.09%)
AAPL : 278.78 (-0.68%)
SMCI : 34.69 (+1.34%)
F : 13.03 (-0.84%)
EL : 105.13 (+1.26%)
MRK : 99.72 (-1.16%)
GSK.LN : 1,805.000 (-1.15%)
DIS : 105.30 (-0.16%)
NOVOB.C.DX : 310.650 (+1.82%)
TSLA : 455.00 (+0.10%)
BNC.LN : 813.000 (-0.85%)
More news for this symbol

Barchart Technical Opinion

Strong buy

The Barchart Technical Opinion rating is a 100% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

3rd Resistance Point 1,862.500
2nd Resistance Point 1,848.000
1st Resistance Point 1,826.500
Last Price 1,805.000
1st Support Level 1,790.500
2nd Support Level 1,776.000
3rd Support Level 1,754.500

See More

52-Week High 1,853.500
Last Price 1,805.000
Fibonacci 61.8% 1,620.098
Fibonacci 50% 1,548.000
Fibonacci 38.2% 1,475.902
52-Week Low 1,242.500

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot